Royalty Pharma plc (RPRX)
NASDAQ: RPRX · Real-Time Price · USD
58.43
-0.59 (-1.00%)
At close: Jul 31, 2026, 4:00 PM EDT
57.00
-1.43 (-2.45%)
Pre-market: Aug 3, 2026, 4:03 AM EDT
Royalty Pharma Employees
Royalty Pharma had 100 employees as of December 31, 2025. The number of employees increased by 1 or 1.01% compared to the previous year.
Employees
100
Change (1Y)
1
Growth (1Y)
1.01%
Revenue / Employee
$24,405,220
Profits / Employee
$8,262,880
Market Cap
33.65B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 100 | 1 | 1.01% |
| Dec 31, 2024 | 99 | 10 | 11.24% |
| Dec 31, 2023 | 89 | 14 | 18.67% |
| Dec 31, 2022 | 75 | 9 | 13.64% |
| Dec 31, 2021 | 66 | 15 | 29.41% |
| Dec 31, 2020 | 51 | 16 | 45.71% |
| Dec 31, 2019 | 35 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| BeOne Medicines AG | 12,000 |
| BioNTech SE | 7,807 |
| Moderna | 4,700 |
| Genmab | 3,088 |
| Incyte | 2,844 |
| Alnylam Pharmaceuticals | 2,500 |
| argenx SE | 1,863 |
| Insmed | 1,664 |
RPRX News
- 11 days ago - Royalty Pharma buys royalty interest in AstraZeneca cliramitug for $125M upfront - TheFly
- 11 days ago - Royalty Pharma acquires royalty interest in AstraZeneca's cliramitug for up to $425 million from Neurimmune - GlobeNewsWire
- 16 days ago - Royalty Pharma declares third quarter 2026 dividend - GlobeNewsWire
- 18 days ago - Royalty Pharma to announce second quarter 2026 financial results on August 5, 2026 - GlobeNewsWire
- 20 days ago - Royalty Pharma price target raised to $65 from $50 at TD Cowen - TheFly
- 7 weeks ago - Healthcare ETFs: From Broad Exposure to Big Breakthroughs - ETF Trends
- 7 weeks ago - Royalty Pharma Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Royalty Pharma to present at the Goldman Sachs 47th Annual Global Healthcare Conference - GlobeNewsWire